Literature DB >> 6606222

Antibacterial activity of nine oral antibiotics against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis.

O V Renkonen.   

Abstract

The efficacy of nine oral antibiotics were analyzed by the agar dilution method against clinical isolates consisting of 87 beta-lactamase positive and negative Haemophilus influenzae and Branhamella catarrhalis strains and 30 Streptococcus pneumoniae strains. The following drugs were tested: cefaclor, cefalexin, cefadroxil, cefradin, phenoxymethylpenicillin, ampicillin, amoxycillin, erythromycin and doxycycline. Inoculations of 10(4) bacteria/plate were made with a Steers inoculator on Mueller-Hinton agar containing 5% blood. Cefaclor was more effective than the other cefalosporins against all H. influenzae and B. catarrhalis strains, regardless of their beta-lactamase production. Cefaclor and cefradin were more effective than cefalexin and cefadroxil against S. pneumoniae strains. Cefaclor was less effective than erythromycin against pneumococci, B. catarrhalis and beta-lactamase positive H. influenzae strains and equally effective against beta-lactamase negative H. influenzae strains. Cefaclor was less active than doxycycline against the B. catarrhalis and H. influenzae strains and showed similar efficacy as doxycycline against pneumococci.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6606222

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  2 in total

1.  Efficacy of penicillin treatment in purulent maxillary sinusitis. A European multicenter trial.

Authors:  C E Nord
Journal:  Infection       Date:  1988 Jul-Aug       Impact factor: 3.553

2.  Susceptibility testing of macrolide antibiotics against Haemophilus influenzae and correlation of in vitro results with in vivo efficacy in a mouse septicemia model.

Authors:  P B Fernandes; D Hardy; R Bailer; E McDonald; J Pintar; N Ramer; R Swanson; E Gade
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.